|Bid||44.14 x 800|
|Ask||176.52 x 1200|
|Day's Range||110.01 - 113.26|
|52 Week Range||107.08 - 159.11|
|Beta (5Y Monthly)||1.53|
|PE Ratio (TTM)||58.11|
|Forward Dividend & Yield||0.80 (0.69%)|
|Ex-Dividend Date||Mar 14, 2022|
|1y Target Est||N/A|
LARGO, Fla., May 24, 2022--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2022 to all shareholders of record as of June 15, 2022.
LARGO, Fla., May 04, 2022--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2022.
LARGO, Fla., May 04, 2022--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately-held In2Bones Global, Inc. (In2Bones), on a cash-free, debt-free basis, for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period. The transaction is not subject to a financing condition. The transaction is subject to customary closing conditions, including receipt of U.S. regulatory approval,